Recent News

• 03.27.2026 - ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research
• 03.25.2026 - ADMA Biologics Addresses Misleading Short-Seller Report
• 03.02.2026 - ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
• 02.25.2026 - ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Recent Filings

• 03.27.2026 - EX-99.1 EX-99.1
• 03.27.2026 - 8-K Current report
• 03.26.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.17.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2026 - 144 Report of proposed sale of securities
• 03.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.09.2026 - 144 Report of proposed sale of securities